1. Extrapulmonary small cell: a novel case of small cell carcinoma of the thyroid gland

   • Douglas F. Beach
   • William J. Klump
   • Alexandre Hageboutros

   Case Report 05 June 2011 Pages: 1405 - 1408

   

2. ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study

   • Qiu-li Li
   • Fu-jin Chen
   • An-kui Yang

   Original Paper 08 July 2011 Pages: 1409 - 1417

   

3. A previously unreported malignancy of the thyroid

   • Bulent Cetin
   • Suleyman Buyukberber
   • Mustafa Benekli

   Case Report 07 July 2011 Pages: 1418 - 1420

   

4. GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma

   • Jean-Philippe Spano
   • Y. Vano
   • L. Leenhardt

   Original Paper 25 September 2011 Pages: 1421 - 1428

   

5. Elevated content of osteopontin in plasma and tumor tissues of patients with laryngeal and hypopharyngeal carcinoma associated with metastasis and prognosis

   • Yong Li
   • Liang Li
   • Jian Guang Lu

   Original Paper 26 June 2011 Pages: 1429 - 1434

   

6. Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma

   • M. Grimm
   • M. Lazariotou

   Original Paper 19 August 2011 Pages: 1435 - 1447

   

7. The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapy

   • Yanqin Yang
   • Jize Xuan
   • Jinming Yu

   Original Paper 23 July 2011 Pages: 1448 - 1455

   

8. Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes

   • Yanhong Zhou
   • Wei Wang
   • Guiyuan Li

   Original Paper 20 October 2011 Pages: 1456 - 1462

   

9. Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer

   • Alexandros Georgolios
   • Anna Eleftheriadou
   • Kostandinos Charalabopoulos

   Review Article 22 November 2011 Pages: 1463 - 1467

   

10. Impairment of breast cancer cell invasion by COX-2-specific inhibitor NS398: roles of CXCR4 and of uPA system

    • Henriqueta Coimbra Silva
    • Vera Alves
    • Fernando Regateiro

    Original Paper 03 June 2011 Pages: 1468 - 1476

    

11. Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission

    • Michael Mark
    • Beat Thürlimann

    Letter to the Editor 12 June 2011 Pages: 1477 - 1478

12. CD44⁺/CD24⁻ cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast

    • Daniel Guimarães Tiezzi
    • Fernando Antonio Mourão Valejo
    • Jurandyr Moreira de Andrade

    Original Paper 29 June 2011 Pages: 1479 - 1485

    

13. Trastuzumab and lapatinib modulation of HER2 tyrosine/threonine phosphorylation and cell signaling

    • D. Kostyal
    • R. S. Welt
    • S. Welt

    Original Paper 16 July 2011 Pages: 1486 - 1494

    

14. Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis

    • Nuttapong Ngamphaiboon
    • Tracey L. O’Connor
    • Ellen B. Kossoff

    Original Paper 05 August 2011 Pages: 1495 - 1501

15. Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients

    • Mahdieh Salimi
    • Hossein Mozdarani
    • Keivan Majidzadeh

    Original Paper 18 August 2011 Pages: 1502 - 1509

    

16. Leptin and breast cancer: an overview

    • Mehmet Artac
    • Kadri Altundag

    Review Article 30 August 2011 Pages: 1510 - 1514

17. Absence of human papillomavirus sequences in epithelial breast cancer in a Mexican female population

    • Lisbeth Herrera-Romano
    • Nora Fernández-Tamayo
    • Mauricio Salcedo

    Short Communication 11 September 2011 Pages: 1515 - 1517

18. Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers

    • Guzin Gonullu Demirag
    • Yurdanur Sullu
    • Idris Yucel

    Original Paper 25 September 2011 Pages: 1518 - 1522

    

19. Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer

    • Steve R. Martinez
    • Warren H. Tseng
    • Richard J. Bold

    Original Paper 08 October 2011 Pages: 1523 - 1528

    

20. Genetic alterations of the WWOX gene in breast cancer

    • Seda Ekizoglu
    • Mahmut Muslumanoglu
    • Nur Buyru

    Original Paper 08 October 2011 Pages: 1529 - 1535

    

21. Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer

    • H. Wong
    • S. Lau
    • T. Yau

    Original Paper 08 October 2011 Pages: 1536 - 1542

22. Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients

    • Xuefeng Bai
    • Feng Jin
    • Minjie Wei

    Original Paper 30 October 2011 Pages: 1543 - 1553

    

23. Girdin protein: a new potential distant metastasis predictor of breast cancer

    • Caigang Liu
    • Yanjun Zhang
    • Feng Jin

    Original Paper 25 November 2011 Pages: 1554 - 1560

    

24. Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese

    • Da Pang
    • Yashuang Zhao
    • Yanmei Yang

    Original Paper 11 November 2011 Pages: 1561 - 1568

    

25. Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women

    • Lin Zhao
    • Zhaojin Yu
    • Minjie Wei

    Original Paper 22 November 2011 Pages: 1569 - 1575

    

26. Type 2 diabetes mellitus and prognosis in early stage breast cancer women

    • Muhammet Ali Kaplan
    • Zafer Pekkolay
    • Abdurrahman Isikdogan

    Original Paper 15 November 2011 Pages: 1576 - 1580

    

27. GGC_n polymorphism of eRF3a/GSPT1 gene and breast cancer susceptibility

    • Mahboobe Miri
    • Simin Hemati
    • Manoochehr Tavassoli

    Original Paper 19 November 2011 Pages: 1581 - 1585

    

28. High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer

    • Badovinac Črnjević Tanja
    • Spagnoli Giulio
    • Šarić Nera

    Original Paper 25 November 2011 Pages: 1586 - 1591

29. Erratum to: High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer

    • Tanja Badovinac-Črnjević
    • Giulio Spagnoli
    • Nera Šarić

    Erratum 31 January 2012 Pages: 1592 - 1592

30. Gender differences in lung cancer mortality trends in Andalusia 1975–2008: a joinpoint regression analysis

    • Aurelio Cayuela
    • Susana Rodríguez-Domínguez
    • Eduardo Vigil

    Original Paper 16 June 2011 Pages: 1593 - 1598

    

31. Evaluation of molecular prognostic and predictive factors: an important step towards personalised treatment in non small cell lung cancer

    • Alfredo Tartarone
    • Rose Lerose
    • Michele Aieta

    Review Article 02 June 2011 Pages: 1599 - 1605

    

32. The relationship between Bmi-1 and the epithelial–mesenchymal transition in lung squamous cell carcinoma

    • Jun Huang
    • Yuan Qiu
    • Jianxing He

    Original Paper 08 June 2011 Pages: 1606 - 1613

    

33. Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinib

    • Katsuhiro Masago
    • Yosuke Togashi
    • Michiaki Mishima

    Original Paper 21 July 2011 Pages: 1614 - 1621

    

34. DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy

    • Dairong Li
    • Qi Zhou
    • Qiying Li

    Original Paper 31 July 2011 Pages: 1622 - 1628

35. Long-term chemotherapy may prolong survival in advanced non-small-cell lung cancer among responders to first-line chemotherapy

    • Tomonori Hirashima
    • Hidekazu Suzuki
    • Ichiro Kawase

    Original Paper 19 August 2011 Pages: 1629 - 1637

    

36. Combination of narrow band imaging (NBI) and autofluorescence imaging (AFI) videobronchoscopy in endoscopic assessment of lung cancer extension

    • Bojan Zaric
    • Branislav Perin
    • Milan Antonic

    Original Paper 09 August 2011 Pages: 1638 - 1642

37. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis

    • Peng Xu
    • Xiao-Lan Xu
    • Yan-Bei Zhang

    Original Paper 28 August 2011 Pages: 1643 - 1647

    

38. Loss of Bad expression confers poor prognosis in non-small cell lung cancer

    • Yi Huang
    • Dan Liu
    • Weimin Li

    Original Paper 15 September 2011 Pages: 1648 - 1655

    

39. Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival

    • Li Guo
    • Shu-Ping Bai
    • Xiao-Hong Wang

    Original Paper 18 September 2011 Pages: 1656 - 1662

    

40. Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma

    • Kyoichi Kaira
    • Yasuhisa Ohde
    • Nobuyuki Yamamoto

    Original Paper 24 September 2011 Pages: 1663 - 1672

    

41. MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis

    • Lan-tao Chen
    • Shi-dong Xu
    • Sheng-fa Wang

    Original Paper 04 November 2011 Pages: 1673 - 1680

    

42. MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance

    • Liang Luo
    • Ting Zhang
    • Yong Song

    Original Paper 13 October 2011 Pages: 1681 - 1686

    

43. Chemotherapy with concurrent brain and thoracic radiotherapy in brain-only metastases of treatment naive small-cell lung cancer: a phase II study

    • Li-kun Chen
    • He Huang
    • Wei-dong Wei

    Original Paper 19 August 2011 Pages: 1687 - 1692

    

44. Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer

    • Hanan Ahmed Wahba
    • Hend Ahmed El-Hadaad
    • Ehab Atef Abd-Ellatif

    Original Paper 26 June 2011 Pages: 1693 - 1698

    

45. Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma

    • Marco K. C. Hui
    • Kenneth K. Y. Lai
    • Simon Law

    Original Paper 16 November 2011 Pages: 1699 - 1706

    

46. Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenocarcinoma

    • Ulas Darda Bayraktar
    • Soley Bayraktar
    • Alberto J. Montero

    Short Communication 28 October 2011 Pages: 1707 - 1710

    

47. Correlational study of vascular endothelial growth factor expression and microvessel density in primary malignant gastric lymphoma

    • Lin Xie
    • Li-Da Shen
    • Ji-Lan Yang

    Original Paper 28 June 2011 Pages: 1711 - 1715

    

48. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis

    • Jieer Ying
    • Qi Xu
    • Liming Zhu

    Original Paper 01 June 2011 Pages: 1716 - 1722

    

49. Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population

    • Yong-ping Mu
    • Xiu-lan Su

    Original Paper 23 November 2011 Pages: 1723 - 1732

    

50. Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient

    • Chengcheng Gao
    • Liqun Pang
    • Tianheng Ma

    Original Paper 11 September 2011 Pages: 1733 - 1738